pole hospitalier psychiatrie centre

POLE HOSPITALIER
PSYCHIATRIE CENTRE
CHEF DE PÔLE :
Dr Jean-Claude Samuelian
ADRESSE :
Pôle Psychiatrie Centre – Hôpital de la Conception 147 Bd Baille 13005
MARSEILLE
TELEPHONE :
04 91 43 50 46
COURRIEL :
[email protected]
ECOLE DOCTORALE :
RATTACHEMENTS :
DISCIPLINES D’APPARTENANCES :
SPECIALITÉS :
Psychiatrie
EFFECTIFS
Enseignants-Chercheurs
(PU-PH, MCU-PH, CCA, AHU) :
Personnel Hospitalier (PH, Attaché) :
1 CCA (partagé avec le Pr C LANCON),
2 Assistants Spécialistes
18 PH, 5 demi-journées Attachés
Personnel Technique :
Personnel Administratif :
7,3 ETP Secrétaires,
7,8 ETP AS,
6 ETP Adjoints administratifs
Etudiants :
16 Internes,
22 Externes
PERSONNELS RATTACHÉS A UNE EQUIPE DE RECHERCHE
NOMS :
FONCTIONS :
Jean-Claude Samuelian
PH
National Center for Scientific Research (CNRS), Mediterranean Institute for Cognitive Neuroscience
(INCM, UMR 6193), CHU Timone Hospital, Marseille Cedex 5
Laurent Boyer :
PH
EA 3279 Evaluation Hospitalière : Mesure de la santé perçue, Faculté de Médecine, Laboratoire de
Santé Publique 13385 Marseille Cedex 5
Nicole Cano
PH
EA 3783 Ethique et Philosophie de la Médecine et de la Biologie. Espace Ethique Méditerranéen Hôpital de la Timone - 264 rue Saint-Pierre 13005 Marseille
Pôle hospitalier. Psychiatrie Centre
Mise à jour du 11 mars 2014
1/7
Xavier Zendjidjian
PH
EA 3279 Evaluation Hospitalière : Mesure de la santé perçue, Faculté de Médecine, Laboratoire de
Santé Publique 13385 Marseille Cedex
SERVICES HOSPITALIERS
INTITULÉ :
RESPONSABLE :
DISCIPLINE :
Secteur 13 G 02
Docteur Daniel DASSA
Psychiatrie Générale
INTITULÉ :
RESPONSABLE :
DISCIPLINE :
Secteur 13 G 03
Docteur Jean-Claude SAMUELIAN
Psychiatrie Générale
INTITULÉ :
RESPONSABLE :
DISCIPLINE :
Secteur 13 G 04
Docteur Jean-Marc CHABANNES
Psychiatrie Générale
INTITULÉ :
RESPONSABLE :
DISCIPLINE :
Unité d’Accueil des Urgences Psychiatriques
Docteur Jean-Marc HENRY
Psychiatrie
INTITULÉ :
RESPONSABLE :
DISCIPLINE :
Cellule d’Urgence Médico-Psychologique
Docteur Emmanuel RICHARD
Psychiatrie
PUBLICATIONS ANNÉE 2012
Cousin FR, Samuelian JC.
RÉALITÉ LT, a pharmaco epidemiological study of semiology and therapeutic strategy of
patients with schizophrenia treated by antipsychotic loxapine in routine clinical practice.
Encephale.
2012 Feb; 38(1): 64-74.
Toesca R, Guyon V, Gourdon X, Samuelian JC.
Early psychological care of the French victims of the Costa Concordia shipwreck.
Int Marit Health. 2013; 64(1): 2-6.
Lancon C, Dassa D,
Are cardio vascular risk factors associated with verbal learning and memory impairment
in patients with schizophrenia? A cross-sectional study.
Cardiovasc Psychiatry Neurol. 2012; 2012: 204043.
Boyer L, Dassa D.
Neurocognition, insight and medication nonadherence in schizophrenia: a structural
equation modeling approach.
PLoS One. 2012; 7(10) : e47655.
Boyer L, Dassa D.
Leber's hereditary optic neuropathy associated with schizophrenia.
J Clin Psychiatry. 2012 Sep; 73(9): e1158-9.
Pôle hospitalier. Psychiatrie Centre
Mise à jour du 11 mars 2014
2/7
Michel P, Boyer L.
Psychometric properties of the abbreviated version of the Scale to Assess Unawareness
in Mental Disorder in schizophrenia.
BMC Psychiatry. 2013 Sep 22; 13(1): 229.
Belzeaux R, Boyer L.
Fondamental Academic Centers of Expertise for Bipolar Disorders (FACE-BD)
collaborators. Depressive residual symptoms are associated with lower adherence to
medication in bipolar patients without substance use disorder: Results fromthe FACE-BD
cohort.
J
Affect
Disord.
2013
Sep
4.
doi:pii:
S0165-0327(13)00662-9.
10.1016/j.jad.2013.08.028.
Blanc J, Boyer L.
Metacognition: towards a new approach to quality of life.
Qual Life Res. 2013 Aug 29.
Boyer L, Dassa D.
Association of metabolic syndrome and inflammation with neurocognition in patients with
schizophrenia.
Psychiatry Res. 2013 Jul 10.
Richieri R, Boyer L.
Maintenance transcranial magnetic stimulation reduces depression relapse: A propensityadjusted analysis.
J Affect Disord. 2013 Oct; 151(1): 129-35.
Boyer L.
Measuring quality of life in patients with schizophrenia:an overview.
Expert Rev Pharmacoecon Outcomes Res. 2013 Jun; 13(3): 343-9.
Boyer L.
Single-photon emission computed tomography findings in a patient with Fahr disease
associated with a schizophrenia-like psychosis.
J Clin Psychiatry. 2013 May; 74 (5): e431-2.
Boyer L.
Validation of a functional remission threshold for the Functional Remission of General
Schizophrenia (FROGS) scale.
Compr Psychiatry. 2013 Oct; 54(7): 1016-22.
Malbos E, Boyer L.
Virtual reality in the treatment of mental disorders.
Presse Med. 2013 May 20.
Boyer L, Lançon C.
Evaluating the impact of a quality of life assessment with feedback to clinicians in
patients with schizophrenia: randomised controlled trial.
Br J Psychiatry. 2013 Jun ;202 : 447-53.
Dumas R, Boyer L.
Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness
of
Mental Disorder (SUMD).
Curr Psychiatry Rep. 2013 Jun; 15(6): 361.
Pôle hospitalier. Psychiatrie Centre
Mise à jour du 11 mars 2014
3/7
Baumstarck K, Boyer L.
Self-reported quality of life measure is reliable and valid in adult patients suffering from
schizophrenia with executive impairment.
Schizophr Res. 2013 Jun; 147(1): 58-67.
Basely M, Boyer L.
Distinct patterns of medial temporal impairment in degenerative dementia: a brain
SPECT perfusion study in Alzheimer's disease and frontotemporal dementia.
Eur J Nucl Med Mol Imaging. 2013 Jun; 40(6): 932-42.
Baumstarck K, Boyer L.
Measuring the quality of life in patients with multiple sclerosis in clinical practice: a
necessary challenge.
Mult Scler Int. 2013; 2013: 524894.
Boyer L, Henry JM, Samuelian JC.
Mental Disorders among Children and Adolescents Admitted to a French Psychiatric
Emergency Service.
Emerg Med Int. 2013; 2013: 651530.
Farisse J, Boyer L.
Left Temporopolar Impairment in a Case of Posttraumatic Hypersomnia.
J Head Trauma Rehabil. 2013 Feb 12.
Boyer L.
Quality of life is predictive of relapse in schizophrenia.
BMC Psychiatry. 2013 Jan 9; 13:15.
Lancon C, Dassa D.
Are cardiovascular risk factors associated with verbal learning and memory impairment
in patients with schizophrenia? A cross-sectional study.
Cardiovasc Psychiatry Neurol. 2012; 2012: 204043.
Belzeaux R, Boyer L.
Responder and nonresponder patients exhibit
signatures during major depressive episode.
Transl Psychiatry. 2012 Nov 13; 2: e185.
Boyer L, Dassa D.
Neurocognition, insight and medication
equation modeling approach.
PLoS One. 2012; 7(10): e47655.
different
peripheral
transcriptional
nonadherence in schizophrenia: a structural
Magalon-Bingenheimer K, Zendjidjian X.
Depression in general practitioner.
Presse Med. 2013 Apr; 42(4 Pt 1): 419-28.
Boyer L, Dassa D.
Leber's hereditary optic neuropathy associated with schizophrenia.
J Clin Psychiatry. 2012 Sep; 73(9): e1158-9.
Micoulaud-Franchi JA, Boyer L.
Combining neurophysiological and functional neuroimaging biomarkers to predict rTMS
non-response in depression.
Brain Stimul. 2013 May; 6(3): 461-3.
Pôle hospitalier. Psychiatrie Centre
Mise à jour du 11 mars 2014
4/7
Richieri R, Boyer L.
Equivalent brain SPECT perfusion changes underlying therapeutic efficiency in pharmaco
resistant depression using either high-frequency left or low-frequency right prefrontal
rTMS. Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3; 39(2): 364-70.
Dumas R, Boyer L.
Improvement of health-related quality of life in depression after transcranial magnetic
stimulation in a naturalistic trial is associated with decreased perfusion in precuneus.
Health Qual Life Outcomes. 2012 Jul 28;10:87.
Richieri R, Boyer L.
Psychostimulants in the treatment of depression.
Presse Med. 2013 Mar; 42(3):3 47-52.
Boyer L.
Functional involvement of superior temporal sulcus in quality of life of patients with
schizophrenia.
Psychiatry Res. 2012 May 31; 202(2): 155-60.
Boyer L.
Quality of life among caregivers of patients with schizophrenia: a cross-cultural
comparison of Chilean and French families.
BMC Fam Pract. 2012 Jul 6; 13:42.
Boyer L.
The lack of impact of quality-of-life measures in schizophrenia: a shared responsibility?
Pharmacoeconomics. 2012 Jun 1; 30(6): 531-2; author reply 532-3.
Faget-Agius C, Boyer L.
Schizophrenia with preserved insight is associated with increased perfusion of the
precuneus. J Psychiatry Neurosci. 2012 Sep; 37(5): 297-304.
Richieri R, Boyer L.
Predict the outcome of depression after rTMS using neuroimaging: issue of response or
non-response?
Brain Stimul. 2013 Jan; 6(1): 95-6.
Girard V, Boyer L.
The analysis of a mobile mental health outreach team activity: from psychiatric
emergencies on the street to practice of hospitalization at home for homeless people.
Presse Med. 2012 May; 41(5): e226-37.
Auquier P, Boyer L.
Measuring patients' views: between enthusiasm and reality.
Eur J Cardiothorac Surg. 2012 Apr; 41(4): 829-30.
Gorin-Lazard A, Boyer L.
Is hormonal therapy associated with better quality of life in transsexuals? A crosssectional study.
J Sex Med. 2012 Feb;9(2):531-41.
Zendjidjian X, Boyer L.
Quality of life among caregivers of individuals with affective disorders.
J Affect Disord. 2012 Feb; 136(3): 660-5.
Boyer L.
Insight into illness, neurocognition and quality of life in schizophrenia.
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Mar 30; 36(2): 271-6.
Pôle hospitalier. Psychiatrie Centre
Mise à jour du 11 mars 2014
5/7
Dubois M.
Emotional endophenotypes and bipolar disorder
Encephale. 2012 Dec; 38 Suppl 3: S85-92.
Dubois M.
Emotion endophenotypes in bipolar and schizophrenic disorders.
Encephale. 2012 Dec; 38 Suppl 3: S93-7.
Dubois M.
Temperamental endophenotypes.
Encephale. 2012 Dec; 38 Suppl 3: S70-4.
Emotional reactivity assessment of healthy elderly with an emotion-induction procedure.
Fajula C.
Exp Aging Res. 2013; 39(1): 109-24.
Zendjidjian X, Boyer L.
Quality of life among caregivers of individuals with affective disorders.
J Affect Disord. 2012 Feb;136(3): 660-5.
Cano N, Boyer L.
L'hospitalisation en psychiatrie : point de vue des patients et perspectives éthiques.
Annales Médico-psychologiques 171 (2013) 518-523
Guivarch J, Cano N.
Usage de la contention en psychiatrie : vécu soignant et perspectives éthiques.
Encéphale (2013)
CONTRATS ANNÉE 2012
PHRC : Etude CSA (Cohorte Sujet Agé), CHU Reims, Pr Limosin (Dr Samuelian)
PHRC : « Transposition du Mini-Mental State en langue des signes : le MMS-LS » , Dr
Benoit Drion, GHICL (Lille), investigateur principal (Comité de protection des personnes
Nord Ouest IV) Dr Ciosi, investigateur principal pour le centre n° 3 (AP HM)
Etude IRMf – Patients Schizophrènes, Aripiprazole vs Risperidone - Promoteur :
Qualissima
Coordonateur de l’étude : Pr Olivier Blin, Investigateurs : Dr Zendjidjian et Dr Dassa
(Première inclusion : 17/11/2010 - Dernière inclusion : 21/01/2013 ) Eudract n°2009017673-38
International, multicenter, non-interventional, observational, prospective, cohort study of
patients with persistent symptoms of schizophrenia attending psychiatric outpatient
clinics.
Etude Pattern MN28151 laboratoire ROCHE 2012 – Dr Dassa
Pôle hospitalier. Psychiatrie Centre
Mise à jour du 11 mars 2014
6/7
THESES DE DOCTORAT ANNÉE 2012
Anorexie mentale et image du corps
Geneviève PAILLISSE, Marseille, Faculté de Médecine, 6 janvier 2012
Nouvelle approche des comportements agressifs en Psychiatrie
Pierre CASANOVA, Marseille, Faculté de Médecine, 16 octobre 2012
Pôle hospitalier. Psychiatrie Centre
Mise à jour du 11 mars 2014
7/7